Consumer Confidential: Sorry about your Stage 3 cancer. Here's a bill for $21,000 in charges you thought were covered
by David Lazarus, Los Angeles Times
Aug 09, 2018
3 minutes
When Michele Brough was diagnosed with Stage 3 breast cancer in April, her oncologist wasted no time in reaching out to her insurer, Anthem Blue Cross and Blue Shield, to obtain pre-approval for a drug that would strengthen her immune system to better withstand chemotherapy.
The good news came shortly afterward. "We are pleased to authorize benefits for the service(s)," Anthem informed Brough, 56, by letter.
The chemo began in mid-May, with each session including an injection of the pre-approved drug Neulasta Onpro to stimulate production of white blood cells and help ward off infection.
You’re reading a preview, subscribe to read more.
Start your free 30 days